secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001193125-23-279380
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology raises $4M in registered direct offering; discloses NYSE American equity non-compliance
--------------------------------------------------------------------------------

- Sold 2,424,243 shares at $1.65/sh; warrants exercisable at $1.86/sh for 5.5 years.
- Gross proceeds ~$4M; net to company ~$3.47M; closing expected Nov 17, 2023.
- NYSE American orally advised MAIA it fails stockholders' equity standard ($2.7M vs $4M minimum).
- Company believes after offering stockholders' equity will exceed $4M, addressing non-compliance.
- H.C. Wainwright acted as exclusive placement agent; lock-up agreements for 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312523279380/0001193125-23-279380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312523279380/d614732d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-279380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer